CXCL13 upregulation by tumors induces migration, signaling and functional changes by CXCR5-expressing immune cells, but the specific functional capacity of CXCR5+CD8 T cells versus other CXCR5-expressing cells, including B cells and tumors, is poorly characterized in cancer. This evidence concerns the gene CXCR5 and cancer.